Geron reported $28.05M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Amgen AMGN:US $ 4.42B 680M
Cti Biopharma CTIC:US $ 31.21M 6.18M
Cytokinetics CYTK:US $ 99.84M 18.14M
Esperion Therapeutics ESPR:US $ 71.22M 9.39M
Exelixis EXEL:US $ 335.72M 62.98M
Genmab GEN:DC 1.92B 310M
Geron GERN:US $ 28.05M 749K
Gilead Sciences GILD:US $ 4231M 2162M
Macrogenics MGNX:US $ 67.82M 9.92M
Novartis NOVN:VX 10.86B 895M
Novavax NVAX:US $ 668.88M 174.21M
Pain Therapeutics PTIE:US $ 19.92M 2.1M
Seattle Genetics SGEN:US $ 630.61M 71.1M
YTE INCY:US $ 656.97M 40.27M